Business
ORYZON Finalist at the 2025 European Lifestars Awards
In the Category Post-IPO Raise of the YearMADRID, Spain and CAMBRIDGE, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that it has been selected as a Finalist in the 2025 European Lifestars Awards in the category Post-IPO Raise of the Year for the European Mediterranean region. The Lifestars Awards bring together leading figures from across the
About this update from Oryzon Genomics Sa
[{"type":"image","alt":"Oryzon Genomics, S.A.","displaySize":"","headline":null,"caption":"Oryzon Genomics, S.A.","className":"","disableSlideshowImg":false,"size":{"original":{"width":182,"height":70,"url":"https://media.zenfs.com/en/globenewswire.com/371936053f3f3aceeaf8ca929a3547e2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cNdaqSWVXmpOQnfrePXGFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTEzODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/371936053f3f3aceeaf8ca929a3547e2","width":182,"height":70}},"lazy":false},{"type":"text","content":"In the Category Post-IPO Raise of the Year","length":42,"tagName":"p"},{"type":"text","content":"MADRID, Spain and CAMBRIDGE, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that it has been selected as a Finalist in the 2025 European Lifestars Awards in the category Post-IPO Raise of the Year for the European Mediterranean region.","length":389,"tagName":"p"},{"type":"text","content":"The Lifestars Awards bring together leading figures from across the European life sciences industry, including companies, investors, and investment banks, to celebrate outstanding achievements. These annual awards recognize the individuals, teams, and organizations driving innovation, advancing healthcare solutions, and shaping the future of the sector. For more information about these awards, please visit https://informaconnect.com/european-lifestars-awards/","length":463,"tagName":"p"},{"type":"text","content":"Winners will be announced at the in-person awards ceremony on Monday, November 17, at City Central at the HAC in London.","length":120,"tagName":"p"},{"type":"text","content":"The nomination highlights the successful completion of a €30 million capital increase in a highly challenging market environment. The financing involved the issuance of 12.76 million new shares at €2.35 per share, representing a 15.44% discount to the 5-day volume-weighted average price (VWAP) of €2.779 and a 19.38% discount to the April 22, 2025, closing price of €2.915. Structured as straight equity with no warrants attached, the offering was met with strong demand and was significantly oversubscribed. A U.S.-based institutional investor anchored the round with a €15 million order, while addi...